| Name |
Recombinant Mouse CD8 alpha, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9135-CD
|
| Category |
Protein
|
| Prices |
$429.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Mouse
|
| Nature |
Recombinant
|
| Source |
Mouse myeloma cell line, NS0-derived Lys28-Tyr196, with a C-terminal 10-His tag
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its ability of the immobilized protein to support the adhesion of Jurkat human acute T cell leukemia cells. The ED 50 for this effect is 1-5 μg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
P01731
|
| Gene |
Cd8a
|
| Sequence |
Lys28
|
| Supplier Page |
Shop
|
Immobilized Recombinant Mouse CD8 alpha (Catalog # 9135-CD) supports the adhesion of Jurkat human acute T cell leukemia cells. The ED 50 for this effect is typically 1-5 μg/mL.